迎接第7個年頭的Next Generation Dx Summit，可透過題材廣泛的節目吸收新知，是一個能夠建立起有益人脈、千載難逢的機會，本次將從世界各地聚集超過800位人士。本年度節目從臨床診斷到事業策略，囊括了各式各樣領域議題，包含癌症預測生物標記、伴隨式診斷、傳染病、定點照護、藥局診斷、Cell-Free DNA、商業化、癌症免疫治療與償還等。Next GeneratonDx Summit大幅網羅了診斷領域的重要議題，是個可以聽取不斷急速進步的本領域的最新發表、以及接觸到開發成果的寶貴機會。
講習會 - 查看詳細議程
"The Next Generation Dx Summit brings together key players from all facets of diagnostic development. Its format is very conducive to networking and
learning from the leaders in the field. This is a great meeting for anyone who is serious about pursuing diagnostic technologies anywhere from research to commercialization."
Program Director, Fluxion Biosciences
"The meeting was excellent, one of the best I have attended, and the standard of talks matched to the schedule across the board."
Vice President, Diagnostics, GlaxoSmithKline
"As we begin to move from a centralized lab to a point-of-care setting we have faced many challenges. It has been a very rewarding meeting with the leaders in policy making along with the leaders in development all in the same place."
Pathology, Graves Gilbert Clinic
"Great conference! Most up to date data. Perfect amalgamation between industry, labs, clinicians and regulatory bodies. Highly recommended!"
Clinical Microbiology Fellow, NIH
Stories and Videos from Next Generation Dx Summit 2014
Moderator: Elaine Lyon, Ph.D., Medical Director, Molecular Genetics, ARUP (AMP 2014 President and Member, AMP Professional Relations Committee)
Jordan S. Laser, M.D., Medical Director, Pathology and Laboratory Medicine, North Shore Long Island Jewish Health System (Member, AMP Professional Relations Committee)
Jamie McDonald, MS, Licensed Genetic Counselor, Co-Director, HHT Center of Excellence; Assistant Professor, Department of Pathology, University of Utah
Stephen P. Day, Ph.D., IVD Consultant (Member, AMP Professional Relations Committee)
IMPACT OF PAMA REGULATIONS ON IVDS
Moderator: Bruce Quinn, M.D., Ph.D., Senior Health Policy Specialist, Foley Hoag LLP
The Impact of PAMA on Molecular Tests
Scott V. McGoohan, J.D., Vice President, Reimbursement & Scientific Affairs, American Clinical Laboratory Association
John F. Warren, Senior Director, McDermott+Consulting LLC
Donna Polizio, Associate Director, Government Accounts, Genomic Health
Paul W. Radensky, M.D., Partner, Health Products Regulation Group, McDermott Will & Emery LLP